BACKGROUND: The use of multiple biomarkers representing various etiologic pathways of atherosclerosis may improve the prediction of interindividual variation in the ankle-brachial index (ABI). To this end, we investigated associations of 47 candidate biomarkers with the ABI and presence of peripheral arterial disease (PAD) in African-Americans (AAs) and non-Hispanic whites (NHWs). METHODS: Study participants included 1,291 AAs (71.1% women, mean age, 63.4±9.3 years) and 1,152 NHWs (57.5% women, mean age 58.5±10.1 years) belonging to hypertensive sibships. Peripheral arterial disease was defined as an ABI ≤ 0.90. Circulating levels of 47 candidate biomarkers were log-transformed before analysis because of skewed distribution. Multivariate regression analyses were used to identify biomarkers associated with ABI or PAD independently of age, sex, conventional risk factors, and medication use. RESULTS: After adjustment for covariates, higher levels of nine biomarkers were associated with a lower ABI in AAs (all P ≤ 0.005); these biomarkers were C-reactive protein (CRP), interleukin-6, tumor necrosis factor receptor-II (TNF-R II), lipoprotein(a), N-terminal pro-brain natriuretic peptide (NT-proBNP), pro-atrial natriuretic peptide, C-terminal pro-arginine vasopressin, osteoprotegerin, and fibrinogen. Three biomarkers - myeloperoxidase, NT-proBNP, and D-dimer - were associated with ABI in NHWs (all P ≤ 0.01). C-reactive protein, interleukin-6, TNF-R II, lipoprotein(a), NT-proBNP, pro-atrial natriuretic peptide, D-dimer, and fibrinogen were associated with PAD (all P ≤ 0.005) in AAs after adjustment for covariates. None of the biomarkers were independently associated with PAD in NHWs. CONCLUSION: A multimarker approach improved the prediction of interindividual variation in the ABI in AAs and NHWs, and improved prediction of the presence of PAD in AAs.
BACKGROUND: The use of multiple biomarkers representing various etiologic pathways of atherosclerosis may improve the prediction of interindividual variation in the ankle-brachial index (ABI). To this end, we investigated associations of 47 candidate biomarkers with the ABI and presence of peripheral arterial disease (PAD) in African-Americans (AAs) and non-Hispanic whites (NHWs). METHODS: Study participants included 1,291 AAs (71.1% women, mean age, 63.4±9.3 years) and 1,152 NHWs (57.5% women, mean age 58.5±10.1 years) belonging to hypertensive sibships. Peripheral arterial disease was defined as an ABI ≤ 0.90. Circulating levels of 47 candidate biomarkers were log-transformed before analysis because of skewed distribution. Multivariate regression analyses were used to identify biomarkers associated with ABI or PAD independently of age, sex, conventional risk factors, and medication use. RESULTS: After adjustment for covariates, higher levels of nine biomarkers were associated with a lower ABI in AAs (all P ≤ 0.005); these biomarkers were C-reactive protein (CRP), interleukin-6, tumor necrosis factor receptor-II (TNF-R II), lipoprotein(a), N-terminal pro-brain natriuretic peptide (NT-proBNP), pro-atrial natriuretic peptide, C-terminal pro-arginine vasopressin, osteoprotegerin, and fibrinogen. Three biomarkers - myeloperoxidase, NT-proBNP, and D-dimer - were associated with ABI in NHWs (all P ≤ 0.01). C-reactive protein, interleukin-6, TNF-R II, lipoprotein(a), NT-proBNP, pro-atrial natriuretic peptide, D-dimer, and fibrinogen were associated with PAD (all P ≤ 0.005) in AAs after adjustment for covariates. None of the biomarkers were independently associated with PAD in NHWs. CONCLUSION: A multimarker approach improved the prediction of interindividual variation in the ABI in AAs and NHWs, and improved prediction of the presence of PAD in AAs.
Authors: Matthew A Allison; Michael H Criqui; Robyn L McClelland; JoAnn M Scott; Mary M McDermott; Kiang Liu; Aaron R Folsom; Alain G Bertoni; A Richey Sharrett; Shunichi Homma; Sujata Kori Journal: J Am Coll Cardiol Date: 2006-08-28 Impact factor: 24.094
Authors: Joachim H Ix; Matthew A Allison; Julie O Denenberg; Mary Cushman; Michael H Criqui Journal: J Am Coll Cardiol Date: 2008-06-17 Impact factor: 24.094
Authors: Allison A Ellington; A Rauoof Malik; George G Klee; Stephen T Turner; Andrew D Rule; Thomas H Mosley; Iftikhar J Kullo Journal: Hypertension Date: 2007-09-04 Impact factor: 10.190
Authors: Farhan J Khawaja; Kent R Bailey; Stephen T Turner; Sharon L Kardia; Thomas H Mosley; Iftikhar J Kullo Journal: Mayo Clin Proc Date: 2007-06 Impact factor: 7.616
Authors: Martina Montagnana; Giuseppe Lippi; Cristiano Fava; Pietro Minuz; Clara Lechi Santonastaso; Enrico Arosio; Gian Cesare Guidi Journal: Clin Chem Lab Med Date: 2006 Impact factor: 3.694
Authors: Ana I Casanegra; Julie A Stoner; Alfonso J Tafur; H Anne Pereira; Suman W Rathbun; Andrew W Gardner Journal: Vasc Med Date: 2016-05-07 Impact factor: 3.239
Authors: Aaron R Folsom; Lu Yao; Alvaro Alonso; Pamela L Lutsey; Emil Missov; Frank A Lederle; Christie M Ballantyne; Weihong Tang Journal: Circulation Date: 2015-06-17 Impact factor: 29.690
Authors: Anja Laschkolnig; Barbara Kollerits; Claudia Lamina; Christa Meisinger; Barbara Rantner; Marietta Stadler; Annette Peters; Wolfgang Koenig; Andrea Stöckl; Doreen Dähnhardt; Carsten A Böger; Bernhard K Krämer; Gustav Fraedrich; Konstantin Strauch; Florian Kronenberg Journal: Cardiovasc Res Date: 2014-04-22 Impact factor: 10.787
Authors: Luca Santoro; Pietro Manuel Ferraro; Andrea Flex; Antonio Nesci; Giuseppe De Matteis; Angela Di Giorgio; Vincenzo Zaccone; Giovanni Gambaro; Antonio Gasbarrini; Angelo Santoliquido Journal: Hypertens Res Date: 2016-07-14 Impact factor: 3.872
Authors: Aeron M Small; Jennifer E Huffman; Derek Klarin; Maria Sabater-Lleal; Julie A Lynch; Themistocles L Assimes; Yan V Sun; Donald Miller; Matthew S Freiberg; Alanna C Morrison; Daniel J Rader; Peter W F Wilson; Kelly Cho; Philip S Tsao; Kyong-Mi Chang; Nicholas L Smith; Christopher J O'Donnell; Paul S de Vries; Scott M Damrauer Journal: Arterioscler Thromb Vasc Biol Date: 2020-08-27 Impact factor: 10.514